HER2 is not a cancer subtype but rather a pan-cancer event and is highly enriched in AR-driven breast tumors.
Background: Approximately one in five breast cancers are driven by amplification and overexpression of the human epidermal growth factor receptor 2 (HER2) receptor kinase, and HER2-enriched (HER2E) is one of four major transcriptional subtypes of breast cancer. We set out to understand the genomics...
| Publicado en: | Breast Cancer Research Vol. 20; pp. 1 - 17 |
|---|---|
| Autores principales: | , |
| Formato: | Journal Article |
| Publicado: |
BioMed Central
1/30/2018
|
| Acceso en línea: | Ver este registro en EBSCOhost |